Research

Long Term Results of Ulnar Shortening Osteotomy for Ulnar Impaction Syndrome

IRB Number: 10176

Institutional Review Board, Hospital for Special Surgery

April 19, 2011

The safety of study participants is our top priority. The trial is approved and periodically reviewed by an Institutional Review Board (IRB), which includes doctors, administrators, ethicists, and members of the general public. The safety of clinical trials is reviewed by the U.S. Food and Drug Administration.

Before enrolling in a clinical trial, the investigator will explain the purpose of the trial, its expected benefits, any possible risks or side effects, and what your role will be. This is the time to ask questions! If you want to join the trial, you must sign the informed consent documents. You can leave a clinical trial at any time without penalty.

For further information, see Understanding Clinical Trials.

Principal Investigator

Michelle G. Carlson, MD

 

Co-Investigators

Andrew J Weiland, MD
Richard H Gelberman, MD
Ryan P Calfee, MD
Duretti Fufa, MD

Summary

This study intends to evaluate long-term outcomes of ulnar shortening osteotomy for Ulnar Impaction Syndrome.  Via phone survey we are collecting post-surgical arm function, symptoms, and patient satisfaction data.

Inclusion/Exclusion Criteria

Inclusion/Exclusion Criteria:


Participants be 18 or older, and must have undergone ulnar shortening Osteotomy with the principal investigator or one of the co-investigators to be eligible for study participation
 

Contact Information

Michelle G. Carlson, MD
carlsonm@hss.edu
 212.774.2727



Request an Appointment